Identification and genomic characterisation of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa

Publication date: Dec 19, 2025

In November 2024, a highly divergent BA.3 related SARS-CoV-2 lineage, designated BA.3.2, was detected in South Africa, marking the first appearance of a BA.3 derived lineage in over two years. Phylogenetic reconstruction places BA.3.2 on an extended branch descending from ancestral BA.3, with no intermediate genomes detected, consistent with a prolonged period of unsampled or isolated evolution. Molecular clock analyses indicate accelerated divergence characteristic of a saltation event, while phylogeographic and demographic analyses point to a southern African origin followed by multiple independent exportations and evidence of ongoing global transmission. Relative to ancestral BA.3, BA.3.2 harbours 39 amino acid substitutions in the spike glycoprotein, two N-terminal domain deletions (Del136-147 and Del243-244), a four-residue insertion (ins214:ASDT), and a large deletion spanning ORF7a, ORF7b, and ORF8. The co-occurrence of D405N and R408S implies epistasis between these sites, while reversions R493Q and H505Y likely enhance ACE2 binding and antibody escape. Extensive remodeling across the spike, including loss of the C15-C136 disulfide bond and substitutions in the SD1 and SD2 domains, may influence spike stability, cleavage, and fusogenicity. The emergence and circulation of BA.3.2 underscores the ongoing potential for highly divergent SARS-CoV-2 variants to arise and spread globally. Despite its limited prevalence, the persistence of BA.3.2 alongside dominant lineages, together with evidence of more recent expansion, indicates that this lineage retains the potential to become of epidemiological concern under favourable conditions.

PDF

Concepts Keywords
10centre Africa
Mandela Australia
Microbiology Ba
Weakest Cov
Detected
Divergent
Lineage
Lineages
Medrxiv
Preprint
Related
Sars
South
Southern
Spike

Semantics

Type Source Name
disease MESH SD1
disease MESH David
disease MESH Respiratory Diseases
disease MESH Meningitis
disease MESH Communicable Diseases
drug DRUGBANK Coenzyme M
disease MESH infections
disease MESH COVID 19
disease MESH NTD
disease MESH long term infection
disease MESH XFG

Download Document

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *